NeuroOne Medical Technologies Corp (NMTC) concluded trading on Thursday at a closing price of $0.58, with 0.48 million shares of worth about $0.28 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -38.99% during that period and on April 17, 2025 the price saw a gain of about 2.66%. Currently the company’s common shares owned by public are about 47.39M shares, out of which, 40.49M shares are available for trading.
Stock saw a price change of 34.73% in past 5 days and over the past one month there was a price change of -42.61%. Year-to-date (YTD), NMTC shares are showing a performance of -29.82% which decreased to -49.60% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.40 but also hit the highest price of $1.39 during that period. The average intraday trading volume for NeuroOne Medical Technologies Corp shares is 274.94K. The stock is currently trading -16.79% below its 20-day simple moving average (SMA20), while that difference is down -37.18% for SMA50 and it goes to -34.36% lower than SMA200.
NeuroOne Medical Technologies Corp (NASDAQ: NMTC) currently have 47.39M outstanding shares and institutions hold larger chunk of about 19.70% of that.
The stock has a current market capitalization of $27.46M and its 3Y-monthly beta is at 0.77. It has posted earnings per share of -$0.27 in the same period. It has Quick Ratio of 2.35 while making debt-to-equity ratio of 0.12. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for NMTC, volatility over the week remained 14.00% while standing at 11.18% over the month.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Craig Hallum on March 29, 2022 offering a Hold rating for the stock and assigned a target price range of between $6 and $2 to it.
